Genetics

This blog post examines a recent integrative genetic study investigating whether circulating metabolites contribute causally to differences in multiple sclerosis severity. Using metabolome-wide Mendelian randomization, genetic colocalization, cis-Mendelian randomization, and brain cell-specific expression data, the researchers identified polyunsaturated fatty acid metabolism as a particularly important pathway. The findings prioritize reduced FADS1 activity—and, more tentatively, altered CYP4F2 function—as potential contributors to greater disease severity, while also implicating amino acid and mitochondrial metabolic processes. Although the results provide a strong mechanistic framework for future research, the study remains a non-peer-reviewed preprint and does not yet support changes to clinical treatment or dietary supplementation.